Yanjie Liu

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Research progress and perspective of transparent electrode materials in flexible perovskite solar cells.

Research progress and perspective of transparent electrode materials in flexible perovskite solar cells.

Journal: Nanoscale

Published: February 25, 2026

Triptolide suppresses melanoma cell growth in vitro and in vivo through the Src-ERK signaling pathway.

Triptolide suppresses melanoma cell growth in vitro and in vivo through the Src-ERK signaling pathway.

Journal: Journal of Cancer

Published: July 12, 2024

Microneedle Patch Delivery of PLCG1-siRNA Efficient Enhanced Temozolomide Therapy for Glioblastoma.

Microneedle Patch Delivery of PLCG1-siRNA Efficient Enhanced Temozolomide Therapy for Glioblastoma.

Journal: Biomacromolecules

Published: January 19, 2024

Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine.

Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: April 20, 2023

Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.

Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: April 20, 2023

Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.

Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: May 27, 2022

Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma.

Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma.

Journal: Nature communications

Published: January 11, 2022

Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy.

Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy.

Journal: Exploration (Beijing, China)

Published: December 28, 2021

Correction to Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.

Correction to Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.

Journal: Nano letters

Published: November 02, 2021

Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy.

Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 29, 2021

Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.

Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.

Journal: Nano letters

Published: February 05, 2020

Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.

Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: January 18, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026